What is ABT's market cap?

Abbott Laboratories (ABT) is a listed stock with a live quote. The latest market cap on this page is $179B.

Where is Abbott Laboratories headquartered?

Abbott Laboratories is headquartered in Abbott Park, IL.

How do I get ABT news from the API?

Call GET /v1/news?tickers=ABT. Add type=news, type=press_release, or type=legal to take one feed. Pro keys search the full archive in real time. Free keys are delayed 15 minutes and return the last year. Signed-out visitors and Free accounts see that same year on this page. Pro sees the full archive.

How far back does ABT news go?

Signed-out visitors and Free accounts see the last year of stock news, press releases, and legal notices for ABT, 15 minutes behind, and each headline links to the publisher. Pro, including the 7-day trial, sees the full archive as headlines are ingested. A Free API key returns the last year. Pro keys search the full archive.

Is the ABT price on this page from the API?

The price and daily change update during the US session for every visitor. That quote is context on this page. It is not part of the news API. The chart is one candle per session from the start of 2020. 1W, 1M, and 1Y group those sessions.

ABT · NYSE

Abbott Laboratories

$103.70 +1.09 (+1.06%)

Company overview

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorders, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as anti-infective clarithromycin, influenza vaccine, and products to regulate the physiological rhythm of the colon.

Sector: Healthcare
Industry: Medical - Devices
Exchange: NYSE
Market cap: $179B
Employees: 114,000
Headquarters: Abbott Park, IL
Website: abbott.com
CEO: Robert Ford
Listed: March 17, 1980
P/E: 28.81
Dividend yield: 2.55%

Company financials

Revenue: $45.1B
Gross profit: $25.4B
Operating income: $8.2B
EBITDA: $10.8B
Net income: $6.3B
EPS: $3.60
Total assets: $110B
Total debt: $34B
Gross margin: 56.38%
Net margin: 13.91%
Earnings yield: 3.47%

Revenue segmentation

By product (FY 2025)

By region (FY 2025)

Showing FY 2025

Price chart

ABT 1D NYSE O101.50H102.90L99.91C102.51+2.00 (+1.99%)Vol10.66M

News

Ticker	Type	Headline	Source	Published
ABT	Press release	Abbott presents new ESMO data showing 30-percent absolute improvement in sensitivity with the whole-genome sequencing Oncodetect® test in colorectal cancer For patients with colorectal cancer, surgery can remove visible cancer, but it can b.	PR Newswire	Oct 23, 9:15:00 AM ET
ABT	Stock news	Abbott's Q3 Earnings Call Focuses on Nutrition Spin-Off and Outlook	Zacks Investment Research	Oct 22, 11:02:29 AM ET
ABT	Stock news	Cologuard Is Working—So Why Isn't Abbott Stock?	MarketBeat	Oct 22, 11:01:35 AM ET
ABT	Press release	Nasdaq and Small Caps Lead Three Day Surge as Crude Slides and Blue Chips Hold Firm Stock Preachers News Commentary - Three sessions into the week, growth and small caps are setting the pace. The Nasdaq Composite jumped 1.04% on the...	PR Newswire	Oct 21, 1:44:00 PM ET
ABT	Press release	Abbott Reports Third-Quarter 2026 Results and Reaffirms Full-Year EPS Guidance Abbott (NYSE: ABT) today announced financial results for the third quarter ended Sept. 30, 2026. Third-quarter sales increased 14.5 percent on a...	PR Newswire	Oct 21, 7:30:00 AM ET
ABT	Press release	Abbott announces its intention to separate its global Nutrition business into an independent, publicly traded company Abbott (NYSE: ABT), the global healthcare leader, today announced its intention to separate its Nutrition business into an.	PR Newswire	Oct 21, 7:25:00 AM ET
ABT	Stock news	2 Industries Beyond AI With Long-Term Demand Drivers for 2027	Zacks Investment Research	Oct 19, 4:00:29 PM ET
ABT	Stock news	Top Wall Street Forecasters Revamp Abbott Expectations Ahead Of Q3 Earnings	Benzinga	Oct 19, 7:23:09 AM ET
ABT	Stock news	Ken Griffin Increased His Position in This Dividend King by a Whopping 546% in Q2. Here's Why It's Still a Buy.	Fool - Investing News	Oct 18, 8:15:00 AM ET
ABT	Stock news	AbbVie's Dividend Keeps Climbing. Is It Still a Buy for Income Investors?	24/7 Wall Street	Oct 17, 8:00:20 AM ET
ABT	Stock news	Abbott Laboratories $ABT Stock: Banque Pictet & Cie SA Increases Stake	Defense World	Oct 17, 3:57:00 AM ET
ABT	Stock news	Countdown to Abbott (ABT) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS	Zacks Investment Research	Oct 16, 10:20:56 AM ET
ABT	Stock news	Why SCHD's Income Is Unshakable This Year: 6 Dividend Aristocrats Doing the Heavy Lifting	24/7 Wall Street	Oct 16, 7:50:38 AM ET
ABT	Stock news	Absolute Software Co. (ABT.TO) (TSE:ABT) Stock Crosses Above 200 Day Moving Average – What’s Next?	Defense World	Oct 16, 2:41:33 AM ET
ABT	Stock news	3 Overlooked Healthcare Dividend Stocks That Could Keep Paying for Decades	24/7 Wall Street	Oct 15, 11:45:58 AM ET
ABT	Stock news	Top Pharmaceutical Stocks To Watch Now – October 13th	Defense World	Oct 15, 2:36:54 AM ET
ABT	Stock news	Medtronic Pays More Today. Abbott Raises Its Dividend Faster.	24/7 Wall Street	Oct 14, 8:15:16 AM ET
ABT	Stock news	The Market Is Flashing Warning Signals Not Seen in Years. Here's Why I Just Bought 3 of SCHD's Dividend Kings.	The Motley Fool	Oct 13, 1:45:02 PM ET
ABT	Stock news	Should You Add Abbott Stock to Your Portfolio Ahead of Q3 Earnings?	Zacks Investment Research	Oct 13, 10:16:06 AM ET
ABT	Stock news	Abbott (ABT) Gains As Market Dips: What You Should Know	Zacks Investment Research	Oct 12, 7:00:50 PM ET